Brokers Offer Predictions for PRE FY2025 Earnings

Prenetics Global Limited (NASDAQ:PRE) – Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Prenetics Global in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn forecasts that the company will post earnings of ($2.08) per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $9.00 price target on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share.

Prenetics Global Stock Performance

Shares of PRE opened at $6.00 on Wednesday. Prenetics Global has a 1 year low of $2.85 and a 1 year high of $7.84. The stock has a market capitalization of $51.67 million, a P/E ratio of -1.50 and a beta of -0.30. The company’s fifty day moving average is $5.28 and its two-hundred day moving average is $5.08.

Prenetics Global (NASDAQ:PRE) last released its earnings results on Wednesday, November 27th. The company reported ($0.84) earnings per share (EPS) for the quarter. Prenetics Global had a negative net margin of 191.73% and a negative return on equity of 16.45%.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.